Published in Clin Interv Aging on January 01, 2008
Diagnosis and treatment of chronic constipation--a European perspective. Neurogastroenterol Motil (2011) 1.99
The treatment of irritable bowel syndrome. Therap Adv Gastroenterol (2009) 0.84
Chronic constipation in the elderly: a primer for the gastroenterologist. BMC Gastroenterol (2015) 0.75
Addition of Lubiprostone to polyethylene glycol(PEG) enhances the quality & efficacy of colonoscopy preparation: a randomized, double-blind, placebo controlled trial. BMC Gastroenterol (2016) 0.75
Review of efficacy and safety of laxatives use in geriatrics. World J Gastrointest Pharmacol Ther (2016) 0.75
Functional bowel disorders. Gastroenterology (2006) 20.72
Epidemiology of constipation in North America: a systematic review. Am J Gastroenterol (2004) 4.89
A randomized, multicenter, placebo-controlled trial of polyethylene glycol laxative for chronic treatment of chronic constipation. Am J Gastroenterol (2007) 2.60
Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. Am J Epidemiol (1992) 2.54
SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents. Am J Physiol Cell Physiol (2004) 2.33
The health-related quality of life and economic burden of constipation. Pharmacoeconomics (2005) 2.14
Lubiprostone, a locally acting chloride channel activator, in adult patients with chronic constipation: a double-blind, placebo-controlled, dose-ranging study to evaluate efficacy and safety. Aliment Pharmacol Ther (2007) 2.08
Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Am J Physiol Gastrointest Liver Physiol (2006) 1.94
Systematic review on the management of chronic constipation in North America. Am J Gastroenterol (2005) 1.85
Myths and misconceptions about chronic constipation. Am J Gastroenterol (2005) 1.78
Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. Am J Gastroenterol (2002) 1.63
Multicenter, 4-week, double-blind, randomized, placebo-controlled trial of lubiprostone, a locally-acting type-2 chloride channel activator, in patients with chronic constipation. Am J Gastroenterol (2007) 1.57
Structure and function of clc channels. Annu Rev Physiol (2005) 1.48
Distribution of ClC-2 chloride channel in rat and human epithelial tissues. Am J Physiol Cell Physiol (2002) 1.44
Distinct populations of sensory neurons mediate the peristaltic reflex elicited by muscle stretch and mucosal stimulation. J Neurosci (1994) 1.19
Diversity of Cl(-) channels. Cell Mol Life Sci (2006) 1.15
Increasing oral fluids in chronic constipation in children. Gastroenterol Nurs (1999) 0.97
Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. Gastroenterology (2012) 4.13
Lubiprostone: a chloride channel activator. J Clin Gastroenterol (2007) 1.24
Patient perceptions of the risks and benefits of infliximab for the treatment of inflammatory bowel disease. Inflamm Bowel Dis (2008) 1.13
A quality improvement project significantly increased the vaccination rate for immunosuppressed patients with IBD. Inflamm Bowel Dis (2013) 1.12
Fecal transplantation: beyond the aesthetic. Gastroenterology (2013) 1.07
Farm animals and inflammatory bowel disease: old MacDonald had poor hygiene. Gastroenterology (2008) 0.75
IBD LIVE Series-Case 8: Treatment Options for Refractory Esophageal Crohn's Disease and Hidradenitis Suppurativa. Inflamm Bowel Dis (2017) 0.75